BEAMSTART Logo

Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected

GlobeNewswire LogoGlobeNewswire2d ago

Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected - GlobeNewswire

Quick Summary:

Leading generic manufacturers have also strengthened their presence by launching affordable generics of blockbuster brands, which are widely preferred due to their cost-effectiveness.” Tonix Pharmaceuticals Holding Corp.(NASDAQ: TNXP) Granted FDA Fast Track Designation for Tonmya™ for the Management of Fibromyalgia – Fast Track is designed to expedite FDA review of important new drugs to treat serious conditions and fill an unmet medical needFast Track designation for Tonmya recognizes fibromyalgia as a serious condition impacting more than 10 million U.S.adults NDA submission on track for second half 2024Tonmya has the potential to be the first new drug for treating fibromyalgia in more than 15 years Tonix Pharmaceuticals Holding Corp.(Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that the U.S.

"Understandably, many patients with a chronic pain condition such as fibromyalgia also experience depression and anxiety, and importantly we found that Lyrica helped reduce pain in patients regardless of the presence of symptoms of these co-morbid conditions.” SAVELLA, registered trademarks of Allergan Pharmaceuticals International Limited, an AbbVie company (NYSE: ABBV), is an FDA-approved prescription medication for the management of fibromyalgia, a common, chronic condition that causes widespread pain.

Fifty-one percent and 55 percent of patients on Cymbalta had a 30 percent improvement on the BPI at endpoint (clinically meaningful relief is considered at least 30 percent pain reduction) Pfizer Inc.(NYSE: PFE) originally reported Lyrica reduced pain of fibromyalgia in patients regardless of whether they experienced symptoms of anxiety or depression at the beginning of the study, according to a pooled analysis presented today at the American Academy of Neurology annual meeting.

or

Article Details

Author / Journalist: FN Media Group LLC

Category: Technology

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-07-25 @ 12:30:00 (2 days ago)

News Timezone: GMT +8:00

News Source URL: globenewswire.com

Language: English

Article Length: 1741 words

Reading Time: 10 minutes read

Sentences: 65 lines

Sentence Length: 27 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © GlobeNewswire

News ID: 21772632

View Article Analysis

About GlobeNewswire

Main Topics: Technology

Official Website: globenewswire.com

Update Frequency: 30 posts per day

Year Established: 1998

Headquarters: China

News Last Updated: 1 days ago

Coverage Areas: China

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #116

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected" has 1741 words across 65 sentences, which will take approximately 8 - 15 minutes for the average person to read.

Which news outlet covered this story?

The story "Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected" was covered 2 days ago by GlobeNewswire, a news publisher based in China.

How trustworthy is 'GlobeNewswire' news outlet?

GlobeNewswire is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news.

The outlet is headquartered in China and publishes an average of 30 news stories per day.

It's most recent story was published 1 days ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #21772632
  • URL: https://beamstart.com/news/global-fibromyalgia-treatment-market-projected-172

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2024 BEAMSTART. All Rights Reserved.